Yıl: 2010 Cilt: 34 Sayı: 3 Sayfa Aralığı: 347 - 358 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives

Öz:
The synthesis of 4-amino-2-[(5-mercapto-1,3,4-oxadiazol-2-yl)methyl]-5-(4-methylphenyl)-2,4-dihydro-3H - 1,2,4-triazol-3-one (2) and 4-amino-2-[(4-amino-5-mercapto-4H -1,2,4-triazol-3-yl)methyl]-5-(4-methylphenyl)- 2,4-dihydro-3H -1,2,4-triazol-3-one (5) was performed starting from 2-[4-amino-3-(4-methylphenyl)-5-oxo- 4,5-dihydro-1H -1,2,4-triazol-1-yl]acetohydrazide (1). The treatment of 2 and 5 with 4-fluorobenzaldehyde (for 8) or salicylaldehyde (for 6) afforded the corresponding Schiff bases (6 and 8). The condensation of 5 with phenacyl bromide produced 4-amino-5-(4-methylphenyl)-2-[(6-phenyl-7H-[1,2,4]triazolo[3,4- b][1,3,4]thiadiazin-3-yl)methyl]-2,4-dihydro-3H-1,2,4-triazol-3-one (7). The alkylation of 2 and 8 was carried out by using methyl iodide in basic media. Compounds 3 and 10a,b were prepared by aminoalkylation of 2 and 8 with 4-fluorophenyl piperazine, morpholine, or 4-methyl piperazine in the presence of formaldehyde. The synthesized compounds were screened for their antimicrobial activities and, with the exception of 2, 4, 7, and 9, were found to possess good or moderate activities against the screened bacterial strains except Candida tropicalis and Candida albicans.
Anahtar Kelime:

Konular: Mühendislik, Kimya
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Rawal, R. K.; Phabhakar, Y. S.; Kati, S. B.; De Clercq, E. Bioorg. Med. Chem, 2005, 13, 6771-6776.
  • 2. Bonde, C. G.; Gaikwad, N. J. Bioorg. Med. Chem. 2004, 12, 2151-2161.
  • 3. Rawal, R. K.; Tripathi, R.; Kati, S. B.; Pannecouque, C.; De Clercq, E. Bioorg. Med. Chem. 2007, 15, 1725-1731.
  • 4. Dixit, P. P.; Patil, V. J.; Nair, P. S.; Jain, S.; Sinha, N.; Arora, S. K. Eur. J. Med. Chem. 2006, 41, 423-428.
  • 5. Kaplancikli, Z. A.; Turan-Zitouni G.; ¨ Ozdemir, A.; Revial, G. Eur. J. Med. Chem. 2008, 43, 155-159.
  • 6. Bayrak, H.; Demirbas, A.; Alpay-Karaoglu, S.; Demirbas, N. Eur. J. Med. Chem. 2009, 44, 1057-1066.
  • 7. Chen, M. D.; Lu, S. J.; Yuang, G. P.; Yang, S. Y.; Du, X. L. Heterocyclic Comm. 2000, 6, 421-426.
  • 8. Holla, B. S.; Mahalingan, M.; Karthikeyan, M. S.; Poojary, B.; Akberali, P. M.; Kumari, N. S., Eur. J. Med. Chem. 2005, 40, 1173-1178.
  • 9. Liu, S.; Qian, X.; Song, G.; Chen, J.; Chen, W. J. Florine Chem. 2000, 105, 111-115.
  • 10. Demirbas, N.; Karaoglu, S. A.; Demirbas A.; Sancak, K. Eur. J. Med. Chem. 2004, 39, 793-804.
  • 11. Cai, S.; Li, Q. S.; Borchardt, R. T.; Kuczera, K.; Schowen, R. L. Bioorg. Med. Chem., 2007, 15, 7281-7287.
  • 12. Rao, B. M.; Sangaraju, S.; Srinivasu, M. K.; Madhavan, P.; Devi, M. L.; Kumar, P. R.; Candrasekhar, K. B.; Arpitha, Ch.; Balaji, T. S. J. Pharm. Biomed. Anal. 2006, 41, 1146-1151.
  • 13. Hancu, G.; Gaspar, A.; Gyeresi, A. J. Biochem. Biophys. Methods 2007, 69, 251-259.
  • 14. Yu, L. T.; Ho, M. T.; Chang, C. Y.; Yang, T. K. Tetrahedron: Asymmetry 2007, 18, 949-952.
  • 15. Gupta, A.; Unadkat, J. D.; Mao, Q. J. Pharm. Sci. 2009, 96, 3226-3235.
  • 16. Schiller, S. D.; Fung, H. B. Clinical Therapeutics 2008, 29, 1862-1886.
  • 17. Ashok, M.; Holla, B. S.; Poojary, B. Eur. J. Med. Chem. 2007, 42, 1095-1101.
  • 18. Jin, L.; Chen, J.; Song, B.; Chen, Z.; Yang, S.; Li, Q.; Hu, D.; Xu, R. Bioorg. Med. Chem. Let., 2006, 16, 5036-5040.
  • 19. Bhandari, S. V.; Bothara, K. G.; Raut, M. K.; Patil, A. A.; Sarkate, A. P.; Mokale, V. J. Bioorg. Med. Chem. 2008, 16, 1822-1831.
  • 20. Krasovskii, A. N.; Bulgakov, A. K.; Andrushko, A. P., Krasovskii, I. A.; Dyachenko, A. M.; Bokun, A. A.; Kravchenko, N. A.; Demchenko, A. M. Pharm. Chem. J. 2000, 34, 115-117.
  • 21. Cui, Y.; Dang, Y.; Yang, Y.; Zhang S.; Ji, R. Eur. J. Med. Chem. 2005, 40, 209-214.
  • 22. Holla, B. S.; Veerendra, B.; Shivananda, M. K.; Poojary, B. Eur. J. Med. Chem. 2003, 38, 759-767.
  • 23. Weidinger-Wells, M.; Boggs, C. M.; Foleno, B. D.; Melton, J.; Bush, K.; Goldschmitdt, R. M. ; Hlasta, D. J. Bioorg. Med. Chem. 2002, 10, 2345-2351.
  • 24. Demirba¸s, N.; U˘gurluo˘glu, R. Turk. J. Chem. 2004, 28, 559-571.
  • 25. Demirba¸s, N.; U˘gurluo˘glu, R. Turk. J. Chem. 2004, 28, 679-690.
  • 26. Demirbas, N.; Ugurluoglu, R.; Demirbas, A. Bioorg. Med. Chem. 2002, 10, 3717-3723.
  • 27. Demirbas, N.; Demirbas A.; Karao˘glu, S. A. Russian J. Bioorg. Chem. 2005, 31, 430-440.
  • 28. Demirbas, N.; Demirbas, A.; Karaoglu, S. A.; C¸ elik, E. Arkivoc 2005, (i), 75-91.
  • 29. Bayrak, H., Demirbas A., Demirbas N.; Karaoglu, S. A. Eur. J. Med. Chem. 2009, 44, 4362-4366.
  • 30. National Committee for Clinical Laboratory Standard, NCCLS Document M7-A3, 1993, vol. 13 (25), Willanova, PA., USA.
APA DEMİRBAŞ A, ŞAHİN D, DEMİRBAŞ N, Alpay Karaoğlu Ş, BEKTAŞ H (2010). Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. , 347 - 358.
Chicago DEMİRBAŞ Ahmet,ŞAHİN DENİZ,DEMİRBAŞ NESLİHAN,Alpay Karaoğlu Şengül,BEKTAŞ Hakan Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. (2010): 347 - 358.
MLA DEMİRBAŞ Ahmet,ŞAHİN DENİZ,DEMİRBAŞ NESLİHAN,Alpay Karaoğlu Şengül,BEKTAŞ Hakan Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. , 2010, ss.347 - 358.
AMA DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. . 2010; 347 - 358.
Vancouver DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. . 2010; 347 - 358.
IEEE DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H "Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives." , ss.347 - 358, 2010.
ISNAD DEMİRBAŞ, Ahmet vd. "Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives". (2010), 347-358.
APA DEMİRBAŞ A, ŞAHİN D, DEMİRBAŞ N, Alpay Karaoğlu Ş, BEKTAŞ H (2010). Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turkish Journal of Chemistry, 34(3), 347 - 358.
Chicago DEMİRBAŞ Ahmet,ŞAHİN DENİZ,DEMİRBAŞ NESLİHAN,Alpay Karaoğlu Şengül,BEKTAŞ Hakan Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turkish Journal of Chemistry 34, no.3 (2010): 347 - 358.
MLA DEMİRBAŞ Ahmet,ŞAHİN DENİZ,DEMİRBAŞ NESLİHAN,Alpay Karaoğlu Şengül,BEKTAŞ Hakan Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turkish Journal of Chemistry, vol.34, no.3, 2010, ss.347 - 358.
AMA DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turkish Journal of Chemistry. 2010; 34(3): 347 - 358.
Vancouver DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives. Turkish Journal of Chemistry. 2010; 34(3): 347 - 358.
IEEE DEMİRBAŞ A,ŞAHİN D,DEMİRBAŞ N,Alpay Karaoğlu Ş,BEKTAŞ H "Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives." Turkish Journal of Chemistry, 34, ss.347 - 358, 2010.
ISNAD DEMİRBAŞ, Ahmet vd. "Synthesis and antimicrobial activities of 2-(5-mercapto)- 1,3-oxadiazol-2-ylmethyl-1,2,4-triazol-3-one derivatives". Turkish Journal of Chemistry 34/3 (2010), 347-358.